It's a Pump & Dump. IMHO The article isn't even about VICL..lolol..there is no news
Whitehouse Station, New Jersey, July 29 (Bloomberg) -- Merck & Co., the No. 1 U.S. drugmaker, said it will begin testing an AIDS vaccine in people by the end of the year.
Business Week first reported the plans for human trials in an article in the Aug. 9 issue, published today on Business Week Online (www.businessweek.com).
As with other experimental drugs, the vaccine first will be tested in healthy volunteers. If these tests are successful, the vaccine may move into more advanced studies.
Merck has been working on an AIDS vaccine since 1987, said Gregory Reaves, a company spokesman. The vaccine testing ''is still very preliminary and there's no guarantee of success,'' Reaves said.
Merck is one of several companies that have looked into AIDS vaccines. VaxGen Inc. won the first U.S. Food and Drug Administration approval in June 1998 to start large-scale human trials of an AIDS vaccine. Cel-Sci Corp., Rhone-Poulenc SA, and Chiron Corp. also have worked on vaccine candidates.
VaxGen's efforts are headed by Donald Francis, the company's president and a leading researcher in deadly contagious diseases. In the 1970's, Francis played a key role in battling the first outbreak of Ebola in Africa, as well as fighting cholera and smallpox.
Merck, based in Whitehouse Station, New Jersey, fell 1 3/4 to 66 3/4.
Jul/29/1999 18:08
For more stories from Bloomberg News, click here.
(C) Copyright 1999 Bloomberg L.P.
Any redistribution of Bloomberg content, including by framing or similar means, is expressly prohibited without the prior written consent of Bloomberg L.P. Any reference to the material must be properly attributed to Bloomberg News.
The information herein was obtained from sources which Bloomberg L.P. and its suppliers believe reliable, but they do not guarantee its accuracy. Neither the information, nor any opinion expressed, constitutes a solicitation of the purchase or sale of any securities or commodities.(C) Copyright 1999 Bloomberg L.P. BLOOMBERG, Bloomberg
News, Bloomberg Financial Markets, Bloomberg Television, Bloomberg News Radio are trademarks, tradenames and service marks of Bloomberg L.P.
|
